What to watch with Insulin and Langlebigkeit?

The interplay between insulin and longevity is a key area in aging research. Insulin/IGF-1 signaling is evolutionarily conserved and modulates lifespan in model organisms, but in humans the picture is nuanced. The provided context highlights two relevant DNA variants: rs1801282 in PPARG (Pro12Ala) slightly improves insulin sensitivity, which may support metabolic health and thus longevity. The FOXO3 variant rs2802292 (T allele) is associated with increased longevity in GWAS; FOXO3 is a transcription factor regulated by insulin/IGF-1 that enhances cellular stress resistance. What to watch? First, single SNP effects are small – lifestyle factors like intermittent fasting, caloric restriction, and exercise activate FOXO3 and improve insulin sensitivity far more. Second, a DNA test provides clues, not certainty. Third, for PPARG variants, a diet rich in healthy fats (e.g., olive oil, nuts) may support insulin sensitivity. Fourth, avoid overinterpretation – evidence is mostly at GWAS level, not clinically validated. Fifth, monitor fasting glucose and HbA1c regularly to objectively assess insulin action. The HFE H63D variant (rs1799945) affects iron metabolism, not directly insulin, but iron overload can increase oxidative stress and indirectly worsen insulin resistance – also worth monitoring. In summary, focus on proven lifestyle measures; genetic variants offer modest additional insight.